An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Campath-1H + FK506 and Methylprednisolone for GVHD
- Status
- COMPLETED
- Phase
- PHASE2
Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries
- Status
- COMPLETED
- Phase
- NA
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer
- Status
- WITHDRAWN
- Phase
- NA
Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2